All Stories

  1. Trajectories of positive aspects of caregiving among family caregivers of stroke-survivors: the differential impact of stroke-survivor disability
  2. Implications of long-term care capacity response policies for an aging population: A simulation analysis
  3. Comorbid Visual and Cognitive Impairment
  4. Older person behavioral and psychological symptoms (BPS) and functional limitations mediate the association between older person cognitive impairment and depressive symptoms in the caregiver
  5. Executive Summary: Heart Disease and Stroke Statistics--2014 Update: A Report From the American Heart Association
  6. Heart Disease and Stroke Statistics--2014 Update: A Report From the American Heart Association
  7. Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin
  8. Lifetime cost-effectiveness analysis of ticagrelor in patients with acute coronary syndromes based on the PLATO trial: a Singapore healthcare perspective
  9. Simulating the Impact of Long-Term Care Policy on Family Eldercare Hours
  10. Executive Summary: Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association
  11. Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association
  12. PCV26 Lifetime Cost-Effectiveness Analysis of Ticagrelor in Patients With Acute Coronary Syndromes Based on the Plato Trial: A Singapore Health Care Perspective
  13. Expert estimates of caregiver hours for older Singaporeans with dementia
  14. Chapter 5: Assessing Risk of Bias as a Domain of Quality in Medical Test Studies
  15. Chapter 7: Grading a Body of Evidence on Diagnostic Tests
  16. Chapter 11: Challenges in and Principles for Conducting Systematic Reviews of Genetic Tests used as Predictive Indicators
  17. Methods Guide for Authors of Systematic Reviews of Medical Tests: A Collaboration Between the Agency for Healthcare Research and Quality (AHRQ) and the Journal of General Internal Medicine
  18. Chapter 6: Assessing Applicability of Medical Test Studies in Systematic Reviews
  19. Future living arrangements of Singaporeans with age-related dementia
  20. Depressive symptoms among informal caregivers of older adults: insights from the Singapore Survey on Informal Caregiving
  21. Contemporary Outcome Measures in Acute Stroke Research
  22. Executive Summary: Heart Disease and Stroke Statistics--2012 Update: A Report From the American Heart Association
  23. Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data
  24. Assessing risk of breast cancer in an ethnically South-East Asia population (results of a multiple ethnic groups study)
  25. Heart Disease and Stroke Statistics--2012 Update: A Report From the American Heart Association
  26. Assessing applicability when comparing medical interventions: AHRQ and the Effective Health Care Program
  27. Stakeholders’ perspective on issues and challenges associated with care and treatment of aging-related cognitive impairment disorders in Singapore
  28. Strategies for antiviral stockpiling for future influenza pandemics: a global epidemic-economic perspective
  29. Executive Summary: Heart Disease and Stroke Statistics--2011 Update: A Report From the American Heart Association
  30. The Chronic Kidney Disease Model: A General Purpose Model of Disease Progression and Treatment
  31. Heart Disease and Stroke Statistics--2011 Update: A Report From the American Heart Association
  32. Cost Efficiency of Anticoagulation With Warfarin to Prevent Stroke in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation
  33. Effect of Home Testing of International Normalized Ratio on Clinical Events
  34. Geographic Variation and Trends in Carotid Imaging Among Medicare Beneficiaries, 2001 to 2006
  35. Geographic Variation in Carotid Revascularization Among Medicare Beneficiaries, 2003-2006
  36. An evaluation of patient self-testing competency of prothrombin time for managing anticoagulation: pre-randomization results of VA Cooperative Study #481–The Home INR Study (THINRS)
  37. The Cost of Visual Impairment: Purposes, Perspectives, and Guidance
  38. Cytochrome P450 testing in the treatment of depression
  39. Hypertension Improvement Project: Randomized Trial of Quality Improvement for Physicians and Lifestyle Modification for Patients
  40. Clinical Effectiveness of Coronary Stents in Elderly Persons
  41. Recommendations for a Clinical Decision Support for the Management of Individuals with Chronic Kidney Disease
  42. Hypertension Improvement Project (HIP): study protocol and implementation challenges
  43. Standards for Measures Used for Public Reporting of Efficiency in Health Care: A Scientific Statement From the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research and the American College of Cardiology Foundation
  44. The Headache Management Trial: A Randomized Study of Coordinated Care
  45. Standards for Measures Used for Public Reporting of Efficiency in Health Care
  46. Strategies for Incorporating Resource Allocation and Economic Considerations *
  47. Opportunities for Improving Management of Advanced Chronic Kidney Disease
  48. Utility of the Advanced Chronic Kidney Disease Patient Management Tools: Case Studies
  49. Outcomes of Second Revascularization Procedures after Stent Implantation
  50. Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers for Treating Essential Hypertension
  51. Review of evidence for genetic testing for CYP450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitors
  52. Cost-effectiveness Analysis of Strategies for Diagnosing Celiac Disease
  53. PST5 PROMOTING THE IMPROVEMENT OF STROKE CARE AT THE STATE-LEVEL: CREATING A LEGISLATIVE POLICY REPORT LINKED TO AN EVIDENCE-BASED SIMULATION MODEL
  54. Advanced Chronic Kidney Disease Practice Patterns among Nephrologists and Non-Nephrologists: A Database Analysis
  55. Noninvasive imaging for coronary artery disease: A technology assessment for the Medicare Coverage Advisory Commission
  56. Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent Implantation
  57. Management of Recalled Pacemakers and Implantable Cardioverter-Defibrillators
  58. Changing Physician Knowledge, Attitudes, and Beliefs About Migraine: Evaluation of a New Educational Intervention
  59. Facilitated Process Improvement: An Approach to the Seamless Linkage Between Evidence and Practice in CKD
  60. Linking dementia research to policy: An example using fluorodeoxyglucose positron emission tomography for the diagnosis of Alzheimer's dementia and mild cognitive impairment
  61. Improving the process of developing technical reports for health care decision-makers: Using the Theory of Constraints in the Evidence-Based Practice Centers
  62. Evidence-Based Practice Center network and health technology assessment in the United States: Bridging the cultural gap
  63. A NEW ERA IN EPILEPSY CARE Guidelines address first steps in diagnosis and treatment
  64. Cost-Effectiveness of Antiplatelet Agents in Secondary Stroke Prevention: The Limits of Certainty
  65. Burden of Illness and Satisfaction With Care Among Patients With Headache Seen in a Primary Care Setting
  66. Dissemination of Evidence-based Practice Center Reports
  67. The Impact of Patient Self-Testing of Prothrombin Time for Managing Anticoagulation: Rationale and Design of VA Cooperative Study #481—The Home INR Study (THINRS)
  68. Meta-Analysis of Survival and Relief of Angina Pectoris After Transmyocardial Revascularization
  69. Cost of multiple sclerosis by level of disability: a review of literature
  70. FDG-PET for management of cervical and ovarian cancer
  71. How can modeling best contribute to the assessment of secondary stroke prevention strategies?
  72. Health Policy and Outcomes Research 2004
  73. Testing for von Willebrand Disease in Women With Menorrhagia: A Systematic Review
  74. P2-350 Costs associated with increasing severity of dementia — A review of the literature
  75. When to Stress Over Triptans: A Markov Analysis of Cardiovascular Risk in Migraine Treatment
  76. Charlson Index Comorbidity Adjustment for Ischemic Stroke Outcome Studies
  77. VA Stroke Study: Neurologist care is associated with increased testing but improved outcomes
  78. Consensus Statement: Cardiovascular Safety Profile of Triptans (5-HT1B/1D Agonists) in the Acute Treatment of Migraine
  79. PIN21 COMPARISON OF 30-DAY DIRECT MEDICAL COSTS OF AZITHROMYCIN AND LEVOFLOXACIN FOR PATIENTS HOSPITALIZED WITH COMMUNITY-ACQUIRED PNEUMONIA
  80. Alzheimer Disease: Operating Characteristics of PET— A Meta-Analysis
  81. How strong is the relationship between functional status and quality of life among persons with stroke?
  82. Do Anticoagulation Management Services Improve Care? Implications of the Managing Anticoagulation Services Trial
  83. Making evidence-based practice improvement more than a comforting sentiment
  84. VA Stroke Study: Neurologist care is associated with increased testing but improved outcomes
  85. When Should Functional Neuroimaging Techniques Be Used in the Diagnosis and Management of Alzheimer's Dementia? A Decision Analysis
  86. Headache Management Program Improves Outcome for Chronic Headache
  87. Cross-Calibration of Stroke Disability Measures
  88. Cost-effectiveness and decision analysis research in stroke
  89. PNP14: COST OF MULTIPLE SCLEROSIS BY LEVEL OF DISABILITY
  90. Health Policy in Stroke: Translating What We Know Into What We Do
  91. Racial differences in survival post cerebral infarction among the elderly
  92. Immunization and MS: A summary of published evidence and recommendations
  93. PHP24 USE OF POLICY MODELING TO PROMOTE INFORMED DECISION MAKING: DEVELOPMENT AND APPLICATION OF THE CANADIAN STROKE POLICY MODEL
  94. To What Extent Should Quality of Care Decisions Be Based on Health Outcomes Data?: Application to Carotid Endarterectomy
  95. Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: results of the managing anticoagulation services trial
  96. Cost-effectiveness of ancrod treatment of acute ischaemic stroke: results from the Stroke Treatment with Ancrod Trial (STAT)
  97. CV1: ESTIMATING THE IMPACT OF ANTICOAGULATION QUALITY ON EVENT RATES
  98. WW14: MAKING MODELS BETTER
  99. Improving the Reliability of Stroke Subgroup Classification Using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Criteria Editorial Comment : Classifying the Mechanisms of Ischemic Stroke
  100. Setting the Target for a Better Cervical Screening Test: Characteristics of a Cost-Effective Test for Cervical Neoplasia Screening
  101. Have Randomized Controlled Trials of Neuroprotective Drugs Been Underpowered? : An Illustration of Three Statistical Principles
  102. Accuracy of the Papanicolaou Test in Screening for and Follow-up of Cervical Cytologic Abnormalities: A Systematic Review
  103. Toward Evidence-Based Management of Migraine
  104. Depression and Other Determinants of Values Placed on Current Health State by Stroke Patients : Evidence From the VA Acute Stroke (VASt) Study
  105. New Transient Ischemic Attack and Stroke
  106. Treating QALYs With a Heavy Dose of Social Values: Is the Cure Worth the Cost?
  107. PCV1: THE ATRIAL FIBRILLATION ANTITHROMBOSIS MODEL (AFAM): A GENERAL-PURPOSE TOOL FOR ANALYSIS, POLICY-MAKING, AND EDUCATION
  108. Mathematical Model for the Natural History of Human Papillomavirus Infection and Cervical Carcinogenesis
  109. Quality of Anticoagulation Management Among Patients With Atrial Fibrillation
  110. Racial Variation in Initial Stroke Severity
  111. INCORPORATION OF PATIENT PREFERENCES IN THE TREATMENT OF UPPER URINARY TRACT CALCULI: A DECISION ANALYTICAL VIEW
  112. Incidence and Occurrence of Total (First-Ever and Recurrent) Stroke
  113. Racial Inequity of Access to Carotid Imaging   Response
  114. Race, Presenting Signs and Symptoms, Use of Carotid Artery Imaging, and Appropriateness of Carotid Endarterectomy
  115. INCORPORATION OF PATIENT PREFERENCES IN THE TREATMENT OF UPPER URINARY TRACT CALCULI
  116. Performing Cost-Effectiveness Analysis by Integrating Randomized Trial Data with a Comprehensive Decision Model
  117. Epidemiology of Recurrent Cerebral Infarction : A Medicare Claims Based Comparison of First and Recurrent Strokes on 2-Year Survival and Cost
  118. Determining Clinically Important Differences in Health Status Measures
  119. Utilities for major stroke: Results from a survey of preferences among persons at increased risk for stroke
  120. The value of stroke prevention and treatment
  121. Concerns Regarding Carotid Endarterectomy Guidelines   Response
  122. Multicenter Review of Preoperative Risk Factors for Endarterectomy for Asymptomatic Carotid Artery Stenosis
  123. Sequence Effects, Health Profiles, and the QALY Model: In Search of Realistic Modeling
  124. Guidelines for Carotid Endarterectomy : A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association
  125. Guidelines for Carotid Endarterectomy : A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association
  126. The Stroke Prevention Policy Model: Linking Evidence and Clinical Decisions
  127. Assessing Uncertainty in Cost-Effectiveness Analyses: Application to a Complex Decision Model
  128. Inaccuracy of the International Classification of Diseases (ICD-9-CM) in identifying the diagnosis of ischemic cerebrovascular disease
  129. Knowledge of Risk Among Patients at Increased Risk for Stroke
  130. Primary Care Physician Reported Secondary and Tertiary Stroke Prevention Practices : A Comparison Between the United States and the United Kingdom
  131. Health Status of Individuals With Mild Stroke
  132. Treatment considerations for persons with metastatic prostate cancer: Survival versus out-of-pocket costs
  133. Combining Patient Utility with Health Status Assessment to Improve Medical Decision Making
  134. Combining Patient Utility with Health Status Assessment to Improve Medical Decision Making
  135. Should we just let the anticoagulation service do it?
  136. What Role Do Neurologists Play in Determining the Costs and Outcomes of Stroke Patients?
  137. US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke: Medical Therapy in Patients With Carotid Artery Stenosis
  138. Clinical and Radiographic Findings That Lead to Intervention in Diabetic Patients With Foot Ulcers: A nationwide survey of primary care physicians
  139. Comparison and meta-analysis of randomized trials of carotid endarterectomy for symptomatic carotid stenosis. Goldstein LB, Hasselblad V, Matchar DB, McCrory DC. Neurology 1995;45
  140. Cost-effective models for flutamide for prostate carcinoma patients: Are they helpful to policy makers?
  141. US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke : Carotid Endarterectomy
  142. Comparison and meta-analysis of randomized trials of endarterectomy for symptomatic carotid artery stenosis
  143. US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke : Design, Service Availability, and Common Practices
  144. Accuracy and reliability of apical S3 gallop detection
  145. Stroke Prevention Guidelines
  146. Guidelines for Carotid Endarterectomy : A Multidisciplinary Consensus Statement From the Ad Hoc Committee, American Heart Association
  147. Theories Explaining Racial Differences in the Utilization of Diagnostic and Therapeutic Procedures for Cerebrovascular Disease
  148. Guidelines for Carotid Endarterectomy : A Multidisciplinary Consensus Statement From the Ad Hoc Committee, American Heart Association
  149. Performance of the Serum Cobalamin Assay for Diagnosis of Cobalamin Deficiency
  150. Management of Atrial Fibrillation
  151. Medical Treatment for Stroke Prevention
  152. Similar motor recovery of upper and lower extremities after stroke
  153. Multicenter review of preoperative risk factors for carotid endarterectomy in patients with ipsilateral symptoms
  154. Global Judgments versus Decision-model-facilitated Judgments
  155. The Stroke Prevention Patient Outcomes Research Team. Goals and methods
  156. Cost effectiveness analysis of early zidovudine treatment of HIV infected patients.
  157. Predicting complications of carotid endarterectomy
  158. The Influence of Hyperglycemia on Outcome of Cerebral Infarction
  159. Likelihood ratios for continuous test results—making the clinicians' job easier or harder?
  160. Impact of social support on outcome in first stroke
  161. The Influence of Hyperglycemia on Outcome of Cerebral Infarction
  162. Response
  163. Measurement of motor recovery after stroke. Outcome assessment and sample size requirements
  164. Racial variations in ischemic stroke-related physical and functional impairments
  165. Predicting the outcomes of electrophysiologic studies of patients with unexplained syncope
  166. Likelihood ratios with confidence: Sample size estimation for diagnostic test studies
  167. Symposium Introduction: Technology Assessment and Guideline Development: Concerns and Opportunities for Academic General Internists
  168. A Bayesian Method for Evaluating Medical Test operating Characteristics When Some Patients' Conditions Fail to Be Diagnosed by the Reference Standard
  169. Uniform Priors Aren't a Thing of the Past
  170. Breakout IV. Health professional concerns in the practice setting
  171. Decision Making in the Face of Uncertainty: The Case of Carotid Endarterectomy
  172. Influence of Drugs on the Recovery of Sensorimotor Function After Stroke
  173. Routine intravenous pyelograms before hysterectomy in cases of benign disease: Possibly effective, definitely expensive
  174. Endarterectomy in Carotid Artery Disease
  175. Endarterectomy in carotid artery disease. A decision analysis
  176. Intermediate, Indeterminate, and Uninterpretable Diagnostic Test Results
  177. Isotope-Dilution Assay for Urinary Methylmalonic Acid in the Diagnosis of Vitamin B 12 Deficiency
  178. Transient Ischemic Attach in a Man with Coronary Artery Disease